InMed Pharmaceuticals Inc. (MTRI) stock
Close on Nov 13, 2026Market cap $102.18MP/E –Yield –
Earnings
InMed Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of InMed Pharmaceuticals's earnings releases, newest first
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
InMed Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When InMed Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases InMed Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- News
- Update
- News
- Update
- Update
- News
- Update
- Update
- Update
- News
- Update
- News
See a number that looks wrong?